EARLY CORTICOSTEROIDS AGAINST COVID-19: ONE MORE RISK FOR BRAZILIANS' HEALTH

Resumo

Several drugs without scientifically proven efficacy have been prescribed for the preventive and early treatment of Covid-19 in Brazil, endorsing the Bolsonaro government's denialist policy regarding the pandemic. One type of drug has been part of this cocktail of drugs and stands out in the indication, the corticoids. The reasons and possible consequences of the most popular of these drugs, dexamethasone, are analyzed. The therapeutic value of this medication is presented, including for Covid-19 in more severe cases, but not preventively and early. The responsibilities regarding these practices and the large-scale effects on the Brazilian population are also discussed.